4-Bromo-2,3-difluorophenol

We are 4-Bromo-2,3-difluorophenol CAS:144292-32-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Bromo-2,3-difluorophenol
CAS.NO:144292-32-0
Synonyms:4-Bromo-2,3-difluorophenol
4-bromo-2,3-difluoro-phenol
2,3-difluoro-4-bromophenol
 
Physical and Chemical Properties:
Density 1.9±0.1 g/cm3
Boiling Point 213.3±35.0 °C at 760 mmHg
Melting Point 49-52°C
Molecular Formula C6H3BrF2O
Molecular Weight 208.988
Flash Point 82.8±25.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.550
 
Specification:
Appearance:Off-white to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Bromo-2,3-difluorophenol


Related News: An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.304-55-2 However, in 2018, the World Health Organization (WHO) gave its long-awaited nod to include TCM in its influential book classifying thousands of diseases — its first-ever official endorsement of the ancient practice.2-(1,3,2-Dioxaborinan-2-yl)benzonitrile APIs are generally manufactured through a variety of processes that include.Galato de propilo CAS:121-79-9 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
2,3-Dichlorobenzotrifluoride View Details
N-BOC-Diethanolamine View Details
Glycylglycylglycine View Details
4-Bromodibenzothiophene manufacturer 4-Benzyloxyindole Cas:20289-26-3 manufacturer Perfluorodecyl iodide Cas:423-62-1 manufacturer 1-(1H-Indol-6-yl)ethanone manufacturer 1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene manufacturer